MIT Enterprise Forum: Changes in the Biotech – Pharma Deal
MIT Enterprise Forum of NYC Presents: The Changing Landscape of the Biotech Pharma Deal
Join Biotech and Pharma industry experts as they converse on deal making trends. Learn how you can position your technology and/or company for success in the current environment.
Our seasoned panel will discuss the evolution of deal models in the life science industry from the 1980s to present day. Our panelist will touch upon issues relating to the size of the deals, valuations, early stage /late stage deals, and recent acquisition activity (Takeda/Millennium;AstraZeneca/MedImmune; Imclone/Lilly). A must attend for anyone interested in Biotech Pharma deal making.
Confirmed Moderator:
- Dr. Mark DeWyngaert – MD Huron Consulting Group
Confirmed Panelists:
- Ed Saltzman, President, DefinedHealth
- Tamar D. Howson, MS, MBA, JSB Partners
- Dr. Christine T. Fischette, President, Enzo Therapeutics, Inc.
- Mark J. Simon, President, Williver Group
Thanks to Kenyon & Kenyon LLP for hosting and sponsoring this event!
DATE: Thursday, January 28, 2010
TIME: 5:30pm – 6:00pm: Reception
6:00pm – 7:30pm: Panel Discussion
7:30pm – 8:30pm: Networking
PLACE: Kenyon & Kenyon LLP – MAP
One Broadway
New York, NY 10004
REGISTRATION:
Register here. Free to members of MIT Enterprise Forum, $50 non-members, $10 extra at door. All members and guests are welcome. If you can no longer attend this event, please open the event announcement from our Event List, click on the event registration link, select the Cancel registration for this event button and then hit Submit.
No Comments